ePrints

A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer

Lookup NU author(s): Professor Gareth Veal, Professor Steve Wedge, Dr Christopher Bacon, Professor Philip Sloan, Professor Alastair GreystokeORCiD, Elizabeth Howell, Dr Will Innes, Dr Chris PlummerORCiD, Dr George Petrides, Professor Ruth Plummer

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, Dragoni I, Heinzmann K, Potter S, Salisbury BM, Chenard-Poirier M, Greystoke A, Howell EC, Innes WA, Morris K, Plummer C, Rata M, Petrides G, Keun HC, Banerji U, Plummer R

Publication type: Article

Publication status: Published

Journal: Clinical Cancer Research

Year: 2023

Volume: 29

Issue: 8

Pages: 1429-1439

Print publication date: 15/04/2023

Online publication date: 18/01/2023

Acceptance date: 13/01/2023

ISSN (print): 1078-0432

ISSN (electronic): 1557-3265

Publisher: American Association for Cancer Research

URL: https://doi.org/10.1158/1078-0432.CCR-22-2263

DOI: 10.1158/1078-0432.CCR-22-2263

PubMed id: 36652553

Altmetrics

Share